Avoro Capital Advisors is a global firm focused on funding & investments in biotechnology, life sciences, and specialty therapeutics. Contact us today!

Before joining Avoro Capital, he spent 11 years at HSBC where he was the Regional Head of the Americas, responsible for the management and development of the HSBC Securities Services …

Feb 21, 2023 · NEW YORK– (BUSINESS WIRE)–Avoro Ventures, a global venture capital firm investing in life sciences, announced today that Mark Chin has joined the firm as a Partner, focused on its …

Avoro Capital Advisors focuses on supporting publicly traded biotechnology companies and late-stage private therapeutic companies with strategic assets.

Contact Avoro Capital Advisors today to learn more about our biotechnology and life-science investment opportunities and how you can progess your portfolio.

Apr 4, 2022 · The launch of Avoro Ventures serves as an extension to the established life sciences business at Avoro Capital, creating a distinct, complimentary portfolio of private market investments.

Dec 19, 2024 · Avoro Capital is a global life sciences investment firm with over $6.5 billion in capital primarily focused on supporting emerging life sciences and biotechnology companies.

Feb 15, 2021 · Dr. Behzad Aghazadeh, PhD is the Managing Partner and Portfolio Manager of Avoro Capital. He has over 25 years of experience in the biopharmaceutical industry spanning scientific …

Dec 1, 2023 · Avoro Ventures is an affiliated company of Avoro Capital Advisors, an SEC-registered investment manager based in New York City, with over $4.5 billion in capital primarily focused on life …

Lauren is responsible for leading Avoro’s investor relations and business development efforts. Prior to joining Avoro in 2024, Lauren served as a Managing Director in Institutional Business Development …